212 related articles for article (PubMed ID: 3056732)
1. Deoxyadenosine toxicity and cell cycle arrest in hydroxyurea-resistant S49 T-lymphoma cells.
Albert DA; Nodzenski E
Exp Cell Res; 1988 Dec; 179(2):417-28. PubMed ID: 3056732
[TBL] [Abstract][Full Text] [Related]
2. Deoxyribonucleotide metabolism and cyclic AMP resistance in hydroxyurea-resistant S49 T-lymphoma cells.
Albert DA; Gudas LJ; Nodzenski E
J Cell Physiol; 1987 Feb; 130(2):262-9. PubMed ID: 3029148
[TBL] [Abstract][Full Text] [Related]
3. Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.
Albert DA; Gudas LJ
J Cell Physiol; 1986 May; 127(2):281-7. PubMed ID: 2939095
[TBL] [Abstract][Full Text] [Related]
4. Ribonucleotide reductase activity and deoxyribonucleoside triphosphate metabolism during the cell cycle of S49 wild-type and mutant mouse T-lymphoma cells.
Albert DA; Gudas LJ
J Biol Chem; 1985 Jan; 260(1):679-84. PubMed ID: 2981227
[TBL] [Abstract][Full Text] [Related]
5. Deoxyribonucleoside triphosphate metabolism and the mammalian cell cycle. Effects of hydroxyurea on mutant and wild-type mouse S49 T-lymphoma cells.
Eriksson S; Skog S; Tribukait B; Wallström B
Exp Cell Res; 1987 Jan; 168(1):79-88. PubMed ID: 3096753
[TBL] [Abstract][Full Text] [Related]
6. Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild-type and mutant S49 T lymphoma cells.
Albert DA; Nodzenski E; Yim G; Kowalski J
J Cell Physiol; 1990 May; 143(2):251-6. PubMed ID: 2159014
[TBL] [Abstract][Full Text] [Related]
7. Deoxyadenosine reverses hydroxyurea inhibition of vaccinia virus growth.
Slabaugh MB; Howell ML; Wang Y; Mathews CK
J Virol; 1991 May; 65(5):2290-8. PubMed ID: 2016760
[TBL] [Abstract][Full Text] [Related]
8. Characterization of hydroxyurea (HYU) resistant S49 T lymphoma cells.
Albert DA; Gudas LJ
Adv Exp Med Biol; 1986; 195 Pt B():305-9. PubMed ID: 3020910
[No Abstract] [Full Text] [Related]
9. Deoxyadenosine- and cyclic AMP-induced cell cycle arrest and cytotoxicity.
Albert DA; Nodzenski E; Cruz GH; Kuchibholtla J; Kowalski J
Exp Cell Res; 1991 Nov; 197(1):75-81. PubMed ID: 1655503
[TBL] [Abstract][Full Text] [Related]
10. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
Carter GL; Cory JG
Cancer Res; 1988 Oct; 48(20):5796-9. PubMed ID: 2844392
[TBL] [Abstract][Full Text] [Related]
11. Ribonucleotide reductase from wild type and hydroxyurea-resistant chinese hamster ovary cells.
Lewis WH; Wright JA
J Cell Physiol; 1978 Oct; 97(1):87-97. PubMed ID: 568630
[TBL] [Abstract][Full Text] [Related]
12. Selective resistance of L1210 cell lines to inhibitors directed at the subunits of ribonucleotide reductase.
Carter GL; Cory JG
Adv Enzyme Regul; 1989; 29():123-39. PubMed ID: 2699151
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea-resistant mouse L cells with elevated levels of drug-resistant ribonucleotide reductase activity.
Kuzik BA; Wright JA
Biochem Genet; 1980 Apr; 18(3-4):311-31. PubMed ID: 7004438
[TBL] [Abstract][Full Text] [Related]
14. Bromodeoxyuridine mutagenesis, ribonucleotide reductase activity, and deoxyribonucleotide pools in hydroxyurea-resistant mutants.
Ashman CR; Reddy GP; Davidson RL
Somatic Cell Genet; 1981 Nov; 7(6):751-68. PubMed ID: 7034251
[TBL] [Abstract][Full Text] [Related]
15. Evidence for genetically independent allosteric regulatory domains of the protein M1 subunit of mouse ribonucleotide reductase.
Eriksson S; Gudas LJ; Clift SM; Caras IW; Ullman B; Martin DW
J Biol Chem; 1981 Oct; 256(19):10193-7. PubMed ID: 7024267
[TBL] [Abstract][Full Text] [Related]
16. Effects of deoxyadenosine on ribonucleotide reductase in adenosine deaminase-deficient lymphocytes.
Takeda E; Kuroda Y; Naito E; Yokota I; Saijo T; Hirose M; Miyao M
J Inherit Metab Dis; 1991; 14(1):87-95. PubMed ID: 1830628
[TBL] [Abstract][Full Text] [Related]
17. A series of N-carbamoyloxyurea resistant cell lines with alterations in ribonucleotide reductase: lack of coordination in pyrimidine and purine reductase activity.
Hards RG; Wright JA
Can J Biochem Cell Biol; 1983; 61(2-3):120-9. PubMed ID: 6342725
[TBL] [Abstract][Full Text] [Related]
18. Cell-cycle associated transcriptional regulation of ribonucleotide reductase in L1210 leukemia cells and drug-resistant variants.
Johnson CE; Hughes K; Cory JG
Cancer Commun; 1991; 3(10-11):341-9. PubMed ID: 1760249
[TBL] [Abstract][Full Text] [Related]
19. Role of the M2 subunit of ribonucleotide reductase in regulation by hydroxyurea of the activity of the anti-HIV-1 agent 2',3'-dideoxyinosine.
Gao WY; Zhou BS; Johns DG; Mitsuya H; Yen Y
Biochem Pharmacol; 1998 Jul; 56(1):105-12. PubMed ID: 9698094
[TBL] [Abstract][Full Text] [Related]
20. G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.
Fox RM; Kefford RF; Tripp EH; Taylor IW
Cancer Res; 1981 Dec; 41(12 Pt 1):5141-50. PubMed ID: 6272990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
